Cullen/Frost Bankers’s Indivior Pharmaceuticals INDV Stock Holding History

Cullen/Frost Bankers’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9K	Buy	+607	New	+$22K	﹤0.01%	1017

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Cullen/Frost Bankers's INDV Position: Q2 2026 in Review

Cullen/Frost Bankers opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 607 shares worth $24.9K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings.

57 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Cullen/Frost Bankers held 607 shares of Indivior Pharmaceuticals worth $24.9K as of Q2 2026.
Indivior Pharmaceuticals was a new Cullen/Frost Bankers position in Q2 2026.
Indivior Pharmaceuticals made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1017 holding.
57 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.